Over half of the adults who developed a rare inflammatory syndrome connected to COVID-19 were treated with serious symptoms in intensive care units, Centers for Disease Control and Prevention researchers found.
A total of 221 COVID-19 patients developed an inflammatory syndrome that attacked multiple organ systems about four weeks after their coronavirus diagnosis, an article published to the JAMA Network Open on Wednesday said.
Forty-seven percent of these patients required respiratory support because of the severity of their illness. Most also required mechanical ventilation and 7 percent died, the research showed.
A majority of the patients with the rare syndrome were between ages 19 and 34. They also tended to be male and either Black or Hispanic, the report said.
The researchers also noted that more information would be required in order to properly identify effective treatments for the syndrome.